MétaCan
Menu
Back to cohort
Record W2635405885 · doi:10.1093/ehjci/eux141.028

P300Impact of gender: rivaroxaban for patients with atrial fibrillation in the XANTUS real-world prospective study

2017· article· en· W2635405885 on OpenAlexaff
Camm Aj, Pierre Amarenco, S. Haas, Miriam Bach, Paulus Kirchhof, Silvia Kuhls, Marc Lambelet, Martin van Eickels, Alexander G.G. Turpie

Bibliographic record

VenueEP Europace · 2017
Typearticle
Languageen
FieldMedicine
TopicAtrial Fibrillation Management and Outcomes
Canadian institutionsMcMaster University
Fundersnot available
KeywordsMedicineAtrial fibrillationRivaroxabanInternal medicineCardiologyProspective cohort studyWarfarin

Abstract

fetched live from OpenAlex

On behalf of: the XANTUS Investigators Funding Acknowledgements: Bayer AG Background: Gender differences in outcomes have been seen in patients with atrial fibrillation (AF). Overall in the phase III ROCKET AF randomized controlled trial of rivaroxaban versus warfarin in stroke or systemic embolism prevention in patients with nonvalvular AF, women had a higher risk of stroke but a lower risk of vascular death and bleeding events than men. Recent registry data have also shown that women had a higher risk of stroke than men. Purpose: This study aimed to analyse demographics and clinical characteristics, and assess the impact of gender on rates of thromboembolism, bleeding and death, in patients with nonvalvular AF specifically receiving rivaroxaban in routine clinical practice. Methods: XANTUS is an international, prospective, observational study of consecutive consenting patients with nonvalvular AF newly started on rivaroxaban who were followed up at 3-month intervals for 1 year, or at least 30 days after permanent discontinuation; mean treatment duration was 329 days. The XANTUS database was examined for demographics, clinical characteristics and outcomes by patient gender. All major outcomes (including major bleeding, symptomatic thromboembolic events [stroke, systemic embolism (SE), transient ischaemic attack, myocardial infarction (MI)], and death) were centrally adjudicated. Results: Among the 6,784 patients in the safety population, the analysis was conducted in 4,016 male (59.2%) and 2,765 female (40.8%) patients (missing values for 3 patients). Women were older than men (mean age 73.7 vs 70.0 years; p<0.0001) and were more likely to have age-related comorbidities (e.g. prior stroke/SE/transient ischaemic attack: 20.7% vs 17.9%; p=0.005); men were more likely to have had prior MI (12.8% vs 6.2%; p<0.0001). After adjustment for baseline characteristics, analysis of outcomes by gender showed a similar risk of stroke/SE in both men and women (hazard ratio [HR] 1.04; 95% confidence interval [CI] 0.59–1.84), and nonsignificant trends for men to be at lower risk of ischaemic stroke (HR=0.79; 95% CI 0.39–1.61). Nonsignificant trends were also seen for higher risk of major bleeding (HR=1.32; 95% CI 0.90–1.95) and MI (HR=1.17; 95% CI 0.51–2.68) in men. Conclusion: Unlike other AF populations reported in the literature, outcomes in patients with nonvalvular AF treated with rivaroxaban were generally similar between men and women in this real-world study.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.008
Threshold uncertainty score0.297

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.064
GPT teacher head0.362
Teacher spread0.298 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2017
Admission routes1
Has abstractyes

Explore more

Same venueEP EuropaceSame topicAtrial Fibrillation Management and OutcomesFrench-language works237,207